ACOG Committee Opinion: No. 283, May 2003. New U.S. Food and Drug Administration Labeling on Cytotec (Misoprostol) Use and Pregnancy
- 23 June 2003
- journal article
- Published by Wiley in International Journal of Gynecology & Obstetrics
- Vol. 82 (1) , 137-138
- https://doi.org/10.1016/s0020-7292(03)00248-0
Abstract
On April 17, 2002, the U.S. Food and Drug Administration approved a new label for the use of Cytotec (misprostol) during pregnancy. The new labeling does not contain claims regarding the efficacy and/or safety of Cytotec when it is used for cervical ripening for the induction of labor nor does it stipulate doses or dosing intervals. Therefore, the Committee on Obstetric Practice reminds Fellows that this agent should be used as previously recommended.Keywords
This publication has 0 references indexed in Scilit: